Literature DB >> 26122960

NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade.

Dipon Das1, Shakti Ranjan Satapathy, Sumit Siddharth, Anmada Nayak, Chanakya Nath Kundu.   

Abstract

PURPOSE: 5-Fluorouracil is the most commonly used drug for the treatment of colon cancer, yet clinical resistance to this drug is frequently observed in patients making this drug ineffective. Thus, identification of gene responsible for 5-FU resistance is of utmost importance.
METHODS: Cellular cytotoxicity and expressions of different protein markers in colon cancer cells were measured by MTT assay and Western blotting, respectively. Cell cycle regulation, migration and colony formation ability were measured by FACS, wound-healing assay and clonogenic assay, respectively.
RESULTS: Increased NECTIN-4 expression was observed in 5-FU-resistant (5-FU-R) and 5-FU-exposed HCT-116 cells. A significant increase in the cell proliferation, migration, colony formation, and resistant to 5-FU were noted in 5-FU-R cells, but reverse was observed after silencing of NECTIN-4. Apoptosis caused by 5-FU in 5-FU-R cells after NECTIN-4 knockdown indicates that NECTIN-4 is responsible for 5-FU resistance. Cell survival proteins were upregulated in 5-FU-R and NECTIN-4-over-expressed cells and downregulated in NECTIN-4 knockdown or LY294002-pretreated 5-FU-R cells. Drug combination of BCNU + Resveratrol decreased the cell survival and NECTIN-4 expressions in 5-FU-R cells and NECTIN-4-over-expressed cells.
CONCLUSIONS: Our data suggest that NECTIN-4 is responsible for 5-FU resistance and BCNU + Resveratrol combination can be used to increase the 5-FU sensitivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122960     DOI: 10.1007/s00280-015-2794-8

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  12 in total

1.  Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.

Authors:  Chinmayee Sethy; Kunal Goutam; Deepika Nayak; Rajalaxmi Pradhan; Sefinew Molla; Subhajit Chatterjee; Niranjan Rout; Michael D Wyatt; Satya Narayan; Chanakya Nath Kundu
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

2.  TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions.

Authors:  Sarita Das; Anmada Nayak; Sumit Siddharth; Deepika Nayak; Satya Narayan; Chanakya Nath Kundu
Journal:  Cell Oncol (Dordr)       Date:  2017-09-21       Impact factor: 6.730

3.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

4.  Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.

Authors:  Anmada Nayak; Sarita Das; Deepika Nayak; Chinmayee Sethy; Satya Narayan; Chanakya Nath Kundu
Journal:  Cell Oncol (Dordr)       Date:  2019-01-03       Impact factor: 6.730

5.  The role of GLI1 for 5-Fu resistance in colorectal cancer.

Authors:  Lining Zhang; Ruolan Song; Dongsheng Gu; Xiaoli Zhang; Beiqin Yu; Bingya Liu; Jingwu Xie
Journal:  Cell Biosci       Date:  2017-04-13       Impact factor: 7.133

6.  MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2.

Authors:  Haijun Wu; Yu Liang; Lin Shen; Liangfang Shen
Journal:  Biol Open       Date:  2016-05-15       Impact factor: 2.422

7.  Expression and clinical significance of Nectin-4 in hepatocellular carcinoma.

Authors:  Jie Ma; ZhiYong Sheng; Yang Lv; WenBin Liu; QiYang Yao; TingTing Pan; ZhiJun Xu; ChuanHai Zhang; GeLiang Xu
Journal:  Onco Targets Ther       Date:  2016-01-06       Impact factor: 4.147

8.  MACC1 facilitates chemoresistance and cancer stem cell‑like properties of colon cancer cells through the PI3K/AKT signaling pathway.

Authors:  Jiankai Wang; Wenjuan Wang; Hongyi Cai; Binbin Du; Lijuan Zhang; Wen Ma; Yongguo Hu; Shifang Feng; Guoying Miao
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

9.  Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.

Authors:  Jun Xu; Shouru Zhang; Rong Wang; Xingye Wu; Li Zeng; Zhongxue Fu
Journal:  Biosci Rep       Date:  2017-05-11       Impact factor: 3.840

10.  Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.

Authors:  Sarita Das; Neha Tripathi; Ranjan Preet; Sumit Siddharth; Anmada Nayak; Prasad V Bharatam; Chanakya Nath Kundu
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.